Thrombectomy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022

NEW YORK, Oct. 16, 2017 /PRNewswire/ -- This report on the global thrombectomy devices market projects the demand to increment at a CAGR of 6.1% during the forecast period of 2017 to 2022. The report has been developed by experience market research analysts and aspires to serve as a credible business tool for targeted audiences such as healthcare service provides including hospitals and surgical centers, government regulatory authorities, non-government organizations, clinical research organizations, research laboratories and academic institutes, and research and development companies.

Read the full report: https://www.reportlinker.com/p05143244

Increasing acquisition or collaboration of small specialized hospitals by tier-1 hospitals, increasing prevalence of cerebrovascular and cardiovascular diseases, escalating number of product approvals and patents, ongoing technological advancements in minimally invasive surgeries, favorable reimbursement policies and improving healthcare infrastructure in a number of emerging economies are some of the key factors augmenting the demand in the global thrombectomy devices market.

On the other hand, strict regulatory policies, lack of awareness among the patients pertaining to thrombectomy, which results in delayed treatment for peripheral vascular diseases, lack of product differentiation, adverse effects of thrombectomy devices, and increase in product recalls are a few factors obstructing the market for thrombectomy devices from attaining its true potential. Increasing number of research activities in the field of thrombectomy and diversifying application of ultrasound in vascular treatment are opening new opportunities in the global thrombectomy devices market, whereas strategic acquisitions of business segments and technological advancements in the advent of laser and UV radiation are some of the key trends.

This report on the global thrombectomy devices market explores the current and future prospects of the demand across the globe. The report not only aspires to serve the stakeholders of companies that are engaged in the manufacturing and commercialization of thrombectomy devices, but also is directed towards new entrants who are aiming to enter this market.

This report comprises an elaborate executive summary along with a market snapshot providing overall information on global thrombectomy devices market dynamics, supply chain, cost structure, list of distributors, average pricing, and technological assessment. This section also provides the overall information and data analysis of the global thrombectomy devices market with respect to the leading market segments based on major products, end user, application, and regions.

Global Thrombectomy Devices Market: Segmentations
On the basis of product, the global thrombectomy devices market has been segmented into aspiration, mechanical, ultrasonic, and hydrodynamic. On the basis of end-use, the market for thrombectomy devices has been bifurcated into hospitals, ambulatory surgical centers (ASCs), clinics, and others. Application-wise, this report on the global thrombectomy devices market classifies it into cardiovascular, neurovascular, and peripheral vascular. Geographically, the report takes stock of the potential of thrombectomy devices market in the regions of North America (The U.S.

and Canada), Latin America (Mexico, Brazil, and Argentina), Europe (Germany, France, Spain, The U.K., Italy, and Nordic), Asia Pacific except Japan (China, India, Malaysia, Thailand, Australia, and Singapore), The Middle East and Africa (GCC countries, Nigeria, South Africa, and Israel), and in the country of Japan. For each of these countries, the report provides revenue comparison on the basis of product, end user, and application.

Global Thrombectomy Devices Market: Competitive Landscape
Stryker Corporation, Argon Medical Devices Inc., Boston Scientific Corporation, Medtronic PLC, Penumbra, Inc., Johnson & Johnson, BTG International Ltd., Edwards Lifesciences Corporation, Phenox GmbH, Teleflex Inc., Terumo Corporation, and Spectranetics Corporation are some of the key companies currently operating in the global thrombectomy devices market. The report throws light on the existing competitive landscape, market shares of the companies, analysis of recent strategic decisions such as mergers, acquisitions, collaborations, and product launches, and other details.

Read the full report: https://www.reportlinker.com/p05143244

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

https://www.reportlinker.com


__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker